Project Grant R01HL171508
Award Date 9/1/25
Completion Date 6/30/29
Dollars Obligated $527K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
- The Project Grant award of $673,581 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research project by Ochin, Inc. to assess disparities in asthma care between Latino and non-Hispanic white adults. The project aims to leverage a comprehensive dataset linking electronic health records to community-level social determinants of health data to evaluate factors underlying asthma care utilization disparities. The award runs from March 1, 2025...
- This $188,136 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to develop an Artificial Intelligence-Enabled Echocardiography Interpretation System (AEIS). The principal investigator, Dr. Chieh-Ju Chao, will train with a multidisciplinary mentoring team led by Drs. Bradley Erickson and Fei-Fei Li to advance his skills in visual-linguistic models and large language models. The goal...
- The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $189,000 Project Grant under CFDA #93.837 Cardiovascular Diseases Research program to the University of Colorado-Denver. The 2-year grant, with a period of performance from September 15, 2025 to August 31, 2027, will support research to investigate the role of outdoor air pollution and environmental allergens in driving treatment response in children with acute asthma...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $816,472 project grant to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant, awarded on August 1, 2025 and set to conclude on May 31, 2029, aims to enhance cardiovascular risk prediction and treatment response in obstructive sleep apnea (OSA) patients using advanced AI-based transformer models and multi-modal sleep data. The project will...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $144,989 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop, train, and test deep generative models using computed tomography (CT) images to predict lung injury progression and treatment responses in patients with acute respiratory distress syndrome (ARDS). The goal is to leverage artificial intelligence and image...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to understand disparities in the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The $502,069 award to Mayo Clinic, a non-profit academic medical center, will quantify the moderating effect of socioeconomic status (SES) on the relationship between urban/rural status and HDP. The research...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $310,948 Project Grant to Minnesota Healthsolutions Corporation, a for-profit woman-owned small business, on September 15, 2023. The grant funds the development of an adaptable platform to support patients with behavior change interventions aimed at improving adherence to treatment and prevention for multiple chronic diseases. The platform will utilize remote...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $443,544 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Dasisimulations LLC, a minority-owned small business located in Dublin, Ohio. The grant supports the development and validation of an innovative, AI-driven software platform to automatically perform complex measurements for pre-planning transcatheter aortic valve replacement (TAVR) procedures. The project aims to (1) develop and validate the...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $783,801 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM). The grant, titled "Demonstrating the Feasibility of Democratized Push-Button Autonomous Cardiac MRI Exam in Community Family Health Centers (AutoCMR for FHC)", aims to demonstrate the feasibility of using a push-button, time-resolved 3D...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,453,222 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Mayo Clinic to investigate barriers to timely screening for primary aldosteronism (PA), a common cause of secondary hypertension. The project aims to identify patient, clinician, healthcare system, and societal factors contributing to inadequate and delayed PA screening, and will leverage machine learning analysis of insurance claims and...